scholarly journals Endothelial function in post-menopausal women: effect of folic acid supplementation

2004 ◽  
Vol 19 (4) ◽  
pp. 1031-1035 ◽  
Author(s):  
G. Paradisi
Keyword(s):  
Folic Acid ◽  
Endothelial Function ◽  
Folic Acid Supplementation ◽  
Acid Supplementation ◽  
Menopausal Women ◽  
Post Menopausal

Folic Acid Supplementation Improves Endothelial Function In Eumenorrheic Runners

2005 ◽  
Vol 37 (Supplement) ◽  
pp. S52
Author(s):  
Anne Z. Hoch ◽  
Brock Adams ◽  
Amjadullah Q. Syed ◽  
Amina Y. Syed ◽  
Phillip S. Clifford ◽  
...  
Keyword(s):  
Folic Acid ◽  
Endothelial Function ◽  
Folic Acid Supplementation ◽  
Acid Supplementation

scholarly journals Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects

2004 ◽  
Vol 106 (4) ◽  
pp. 353-358 ◽  
Author(s):  
Richard J. WOODMAN ◽  
David E. CELERMAJER ◽  
Peter L. THOMPSON ◽  
Joseph HUNG
Keyword(s):  
Risk Factors ◽  
Folic Acid ◽  
Endothelial Function ◽  
Healthy Subjects ◽  
Folic Acid Supplementation ◽  
Double Blind ◽  
Acid Supplementation ◽  
Flow Mediated Dilatation ◽  
Artery Disease ◽  
Cad Risk

Folic acid supplementation lowers total plasma homocysteine (tHcy) and improves endothelial function in individuals with coronary artery disease (CAD) and in those with additional CAD risk factors. In the present study, we assessed whether endothelial function is impaired in healthy subjects with hyperhomocysteinaemia but without other CAD risk factors and whether folic acid supplementation improves endothelial function in these subjects. Flow-mediated dilatation (FMD) of the brachial artery was performed on 26 healthy subjects, age 49±2 years (mean±S.E.M.), with high tHcy (15.6±1.5 µmol/l) and 16 healthy age-matched subjects with low tHcy (7.9±0.6 µmol/l; P<0.001). Subjects with high tHcy were then randomized to receive 5 mg/day of folic acid or placebo for 8 weeks in a double-blind cross-over trial with a 4-week washout. FMD was not associated with tHcy and was not different between high and low tHcy groups (7.0±0.6% compared with 6.6±1.2%, P=0.76). Treatment with folic acid decreased tHcy by 34% in hyperhomocysteinaemic subjects (P=0.02 compared with placebo), but had no effect on FMD (+0.5±0.6% compared with -0.7±0.5%; P=0.17 compared with placebo). In healthy subjects with hyperhomocysteinaemia, but without additional cardiovascular risk, endothelial function is unimpaired and folic acid supplementation has no additional effect.

scholarly journals Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia

2016 ◽  
Vol 21 (2) ◽  
pp. 91-98 ◽  
Author(s):  
Suzanne C van Dijk ◽  
Anke W Enneman ◽  
Karin MA Swart ◽  
Janneke P van Wijngaarden ◽  
Annelies C Ham ◽  
...  
Keyword(s):  
Folic Acid ◽  
Endothelial Function ◽  
Vitamin B12 ◽  
Folic Acid Supplementation ◽  
Elderly Individuals ◽  
Acid Supplementation

Effects of Short‐term Folic Acid Supplementation on Brachial Artery Endothelial Function in Habitually Trained and Untrained Postmenopausal Women

2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Jennifer Craig ◽  
Elizabeth C. Akam ◽  
Stephen J. Bailey ◽  
Nick J. Cox ◽  
Richard A. Ferguson ◽  
...  
Keyword(s):  
Folic Acid ◽  
Endothelial Function ◽  
Postmenopausal Women ◽  
Brachial Artery ◽  
Folic Acid Supplementation ◽  
Short Term ◽  
Acid Supplementation

Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation

2002 ◽  
Vol 112 (7) ◽  
pp. 535-539 ◽  
Author(s):  
Kam S Woo ◽  
Ping Chook ◽  
Lindy L.T Chan ◽  
Alice S.P Cheung ◽  
Wing H Fung ◽  
...  
Keyword(s):  
Folic Acid ◽  
Endothelial Function ◽  
Folic Acid Supplementation ◽  
Acid Supplementation
Sign in / Sign up

Export Citation Format

Share Document